Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3′-azido-3′-deoxythymidine
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 172 (1) , 288-294
- https://doi.org/10.1016/s0006-291x(05)80207-4
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1989
- Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnetAntimicrobial Agents and Chemotherapy, 1989
- Anti-retroviral therapy of AIDS and related disorders: General principles and specific development of dideoxynucleosidesPharmacology & Therapeutics, 1989
- Potential drugs for the treatment of AIDSJournal of Antimicrobial Chemotherapy, 1989
- 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1987
- Site-specific mutagenesis of AIDS virus reverse transcriptaseNature, 1987
- PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1986
- Inhibition of HTLV-III/LAV replication by foscarnetBiochemical Pharmacology, 1985
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984